Show simple item record

dc.contributor.authorMotz, Jason T.
dc.contributor.authorFitzmaurice, Maryann
dc.contributor.authorMiller, Arnold
dc.contributor.authorGandhi, Saumil J.
dc.contributor.authorHaka, Abigail S.
dc.contributor.authorGalindo, Luis H.
dc.contributor.authorKramer, John R.
dc.contributor.authorFeld, Michael S.
dc.contributor.authorDasari, Ramachandra Rao
dc.date.accessioned2014-06-05T14:28:45Z
dc.date.available2014-06-05T14:28:45Z
dc.date.issued2006-04
dc.date.submitted2005-10
dc.identifier.issn10833668
dc.identifier.issn1560-2281
dc.identifier.urihttp://hdl.handle.net/1721.1/87644
dc.description.abstractThe rupture of vulnerable atherosclerotic plaque accounts for the majority of clinically significant acute cardiovascular events. Because stability of these culprit lesions is directly related to chemical and morphological composition, Raman spectroscopy may be a useful technique for their study. Recent developments in optical fiber probe technology have allowed for the real-time in vivo Raman spectroscopic characterization of human atherosclerotic plaque demonstrated in this work. We spectroscopically examine 74 sites during carotid endarterectomy and femoral artery bypass surgeries. Of these, 34 are surgically biopsied and examined histologically. Excellent signal-to-noise ratio spectra are obtained in only 1 s and fit with an established model, demonstrating accurate tissue characterization. We also report the first evidence that Raman spectroscopy has the potential to identify vulnerable plaque, achieving a sensitivity and specificity of 79 and 85%, respectively. These initial findings indicate that Raman spectroscopy has the potential to be a clinically relevant diagnostic tool for studying cardiovascular disease.en_US
dc.description.sponsorshipNational Institutes of Health (U.S.) (R01-HL-64675)en_US
dc.description.sponsorshipNational Center for Research Resources (U.S.) (Grant P41-RR-02594)en_US
dc.description.sponsorshipPfizer Inc.en_US
dc.description.sponsorshipCameron and Hayden Lord Foundationen_US
dc.language.isoen_US
dc.publisherSPIEen_US
dc.relation.isversionofhttp://dx.doi.org/10.1117/1.2190967en_US
dc.rightsArticle is made available in accordance with the publisher's policy and may be subject to US copyright law. Please refer to the publisher's site for terms of use.en_US
dc.sourceSPIEen_US
dc.titleIn vivo Raman spectral pathology of human atherosclerosis and vulnerable plaqueen_US
dc.typeArticleen_US
dc.identifier.citationMotz, Jason T., Maryann Fitzmaurice, Arnold Miller, Saumil J. Gandhi, Abigail S. Haka, Luis H. Galindo, Ramachandra R. Dasari, John R. Kramer, and Michael S. Feld. “In Vivo Raman Spectral Pathology of Human Atherosclerosis and Vulnerable Plaque.” Journal of Biomedical Optics 11, no. 2 (2006): 021003. © 2006 Society of Photo-Optical Instrumentation Engineersen_US
dc.contributor.departmentMassachusetts Institute of Technology. Department of Chemistryen_US
dc.contributor.departmentMassachusetts Institute of Technology. Department of Physicsen_US
dc.contributor.departmentMassachusetts Institute of Technology. Spectroscopy Laboratoryen_US
dc.contributor.mitauthorGandhi, Saumil J.en_US
dc.contributor.mitauthorHaka, Abigail S.en_US
dc.contributor.mitauthorGalindo, Luis H.en_US
dc.contributor.mitauthorDasari, Ramachandra Raoen_US
dc.contributor.mitauthorKramer, John R.en_US
dc.contributor.mitauthorFeld, Michael S.en_US
dc.relation.journalJournal of Biomedical Opticsen_US
dc.eprint.versionFinal published versionen_US
dc.type.urihttp://purl.org/eprint/type/JournalArticleen_US
eprint.statushttp://purl.org/eprint/status/PeerRevieweden_US
dspace.orderedauthorsMotz, Jason T.; Fitzmaurice, Maryann; Miller, Arnold; Gandhi, Saumil J.; Haka, Abigail S.; Galindo, Luis H.; Dasari, Ramachandra R.; Kramer, John R.; Feld, Michael S.en_US
mit.licensePUBLISHER_POLICYen_US
mit.metadata.statusComplete


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record